Literature DB >> 16632439

Treatment of childhood diffuse brain stem tumors: comparison of results in different treatment modalities.

Melissa M de Aquino Gorayeb1, Salim Aisen, Wladimir Nadalin, Rodrigo Panico Gorayeb, Heloisa de Andrade Carvalho.   

Abstract

BACKGROUND: Diffuse brainstem tumors in children are rare and its treatment is controversial. Although radiotherapy (RT) used to be the treatment of choice, results remained unsatisfactory. The association of RT with other therapies is common, but lacks scientific data regarding its efficacy. Comparison of results of irradiation alone versus combined treatment modalities is crucial in improving survival.
METHOD: The authors reviewed twenty-four patients with diffuse brainstem tumors, with mean age of 7 years, treated from December 90 to November 99, at the University of Sao Paulo, Brazil. These patients were subdivided in four groups according to the treatment option at the onset of symptoms. Four patients were treated with radiation alone (total dose of 50 Gy to 62.4 Gy), 6 patients with chemotherapy and radiation, 8 with tamoxifen and radiation and 6 with tamoxifen, radiation and chemotherapy. The results of the different groups were them compared.
FINDINGS: Clinical response was observed in 83.3% of our children, briefly followed by progressive disease. Mean survival was 17 months with no statistically significant differences among the groups. Four patients were alive at the end of the study, with a mean survival of 32.4 months, all of them received combined therapy, but with no statistically significant differences.
CONCLUSIONS: Neither the association of radiation therapy with chemotherapy, tamoxifen nor both have showed survival improvement. The prognosis of these patients remains very poor and only investigational trials would justify a highly aggressive approach.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632439     DOI: 10.1007/s12094-006-0094-9

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  21 in total

1.  Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study.

Authors:  L S Lashford; P Thiesse; A Jouvet; T Jaspan; D Couanet; P D Griffiths; F Doz; J Ironside; K Robson; R Hobson; M Dugan; A D J Pearson; G Vassal; D Frappaz
Journal:  J Clin Oncol       Date:  2002-12-15       Impact factor: 44.544

Review 2.  Current management of brain stem gliomas.

Authors:  M S Edwards; M Prados
Journal:  Pediatr Neurosci       Date:  1987

3.  Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas.

Authors:  M Benesch; H Lackner; A Moser; R Kerbl; W Schwinger; R Oberbauer; H G Eder; R Mayer; K Wiegele; C Urban
Journal:  Pediatr Neurosurg       Date:  2001-10       Impact factor: 1.162

4.  Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group.

Authors:  A Broniscer; C C Leite; V L Lanchote; T M Machado; L M Cristófani
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

5.  Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas.

Authors:  Dennis J Kuo; Howard L Weiner; Jeffrey Wisoff; Douglas C Miller; Edmond A Knopp; Jonathan L Finlay
Journal:  J Pediatr Hematol Oncol       Date:  2003-05       Impact factor: 1.289

6.  Hyperfractionated radiation therapy for gliomas of the brainstem in children and in adults.

Authors:  D C Shrieve; W M Wara; M S Edwards; P K Sneed; M D Prados; P H Cogen; D A Larson; V A Levin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

7.  Focal midbrain tumors in children.

Authors:  W P Vandertop; H J Hoffman; J M Drake; R P Humphreys; J T Rutka; D C Amstrong; L E Becker
Journal:  Neurosurgery       Date:  1992-08       Impact factor: 4.654

8.  Contemporary management of adult and pediatric brain stem gliomas.

Authors:  M J Guiney; J G Smith; P Hughes; C Yang; K Narayan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-01-15       Impact factor: 7.038

9.  Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group.

Authors:  A L Albright; R J Packer; R Zimmerman; L B Rorke; J Boyett; G D Hammond
Journal:  Neurosurgery       Date:  1993-12       Impact factor: 4.654

10.  Temozolomide in paediatric high-grade glioma: a key for combination therapy?

Authors:  A C Verschuur; J Grill; A Lelouch-Tubiana; D Couanet; C Kalifa; G Vassal
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

View more
  1 in total

1.  Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.

Authors:  Sara Nagy; Patricia Hafner; Simone Schmidt; Daniela Rubino-Nacht; Sabine Schädelin; Oliver Bieri; Dirk Fischer
Journal:  Trials       Date:  2019-11-21       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.